Recital 5, Regulation (EU) 2026/702

In forcesince 23 Mar 2026

After carrying out an examination of the request, on 8 January 2026, the Commission informed KD Pharma Canada Ltd by letter of its intention to reject the request on the ground that the request did not constitute a case for a change of company name.